Press Releases


Latest News


Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Aug 18, 2009 | Financial Releases

Adamas Pharmaceuticals Signs CRADA with U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including The Novel H1N1 Pandemic Strain
Aug 18, 2009 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11 12